Home
AC Immune

AC Immune Market Share Analysis for August 2026

AC Immune SA, a global leader in developing precision medicine for neurodegenerative diseases (incl. Alzheimer & Parkinson's) with cutting-edge technology platforms

Health > Biotechnology and Pharmaceuticals

Domainacimmune.com

Year Founded2003

Employees51 - 200

Annual Revenue$2M - $5M

AC Immune

AC Immune (including company regionals)

acimmune.com

See more website traffic and engagement information

AC Immune Revenue up to August 2026 is 2M - 5M

revenue generated by AC Immune top domains

AC Immune top domains revenue over 3 years

Revenue for AC Immune top domains

acimmune.com2M - 5M

See more with Sales Intelligence

Total visits to AC Immune's top domains

Understand AC Immune market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

acimmune.com6.3K

See more with Sales Intelligence

Avg. visit duration in AC Immune's top domains

Analyze AC Immune engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

acimmune.com00:01:02

See more with Sales Intelligence

Avg. pageviews on AC Immune's top domains

See how AC Immune keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

acimmune.com2.03

See more with Sales Intelligence

AC Immune top competitors by domain

Top similar sites in August 2026, ranked by their affinity

clinicaltrials.govCompany NameClinicalTrials.govEmployees201 - 500HQUnited States, North Carolina, DurhamAnnual revenue$15M - $25MTotal visits3MHealth > Health - Other

Top technologies used by AC Immune

These are the website technologies, by industry, used by AC Immune top domains

Widget (5)

reCAPTCHA

Advertising (4)

Google Adsense

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

10

See all

News & Signals from AC Immune

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAC Immune had revenue of $18.7M on Aug 5th '26.AC Immune had a negative return on equity of 125.26% and a negative net margin of 1,788.02%.The company had revenue of $18.67 million for the quarter, compared to analyst estimates of $34.08 million.

NewsAC Immune was planning to have revenue of $1.4M on Apr 30th '26.AC Immune reported a $0.19-per-share loss and $1.40 million in revenue in the prior quarter, while analysts expect a full-year loss of approximately $1 per share.

NewsAC Immune is developing viral therapy that enables neurons to produce intrabodies on Jul 21st '26.AC Immune has developed a viral therapy that enables neurons to produce intrabodies, engineered antibodies designed to function inside cells and selectively target harmful forms of TDP-43.